![]() |
Volumn 58, Issue 12, 2009, Pages 1703-
|
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: Does blocking TNFα reduce colitis-associated colorectal carcinogenesis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
INFLIXIMAB;
PLACEBO;
TUMOR NECROSIS FACTOR ALPHA;
CANCER INCIDENCE;
CARCINOGENESIS;
COLITIS;
COLON CROHN DISEASE;
COLORECTAL CARCINOMA;
DISEASE ASSOCIATION;
DRUG SAFETY;
ENTERITIS;
HUMAN;
LETTER;
NONHUMAN;
PRIMARY SCLEROSING CHOLANGITIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
ULCERATIVE COLITIS;
ANTIBODIES, MONOCLONAL;
CELL TRANSFORMATION, NEOPLASTIC;
COLORECTAL NEOPLASMS;
GASTROINTESTINAL AGENTS;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 72549112691
PISSN: 00175749
EISSN: 14683288
Source Type: Journal
DOI: 10.1136/gut.2008.176461 Document Type: Letter |
Times cited : (16)
|
References (5)
|